A discussion about the effectiveness of new cancer drugs and the impact of their high price on patients and doctors.

Guests

  • Randy Burkholder Associate Vice President of Policy, Pharmaceutical Research and Manufacturers of America
  • Dr. Ed Pezalla National Medical Director for Aetna Pharmacy Management, Hartford CT.
  • Kevin LaMartina Patient Resource Navigator, The American Cancer Society, at St. Agnes Hospital, Baltimore, MD.
  • Dr. Neal Meropol Director, Gastrointestinal Cancer Program, Fox Chase Cancer Center, Philadelphia, PA
  • Dr. John Marshall Chief, Division of Hematology/Oncology at Georgetown's Lombardi Comprehensive Cancer Center, Washington, D.C.

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, May 27 2016President Barack Obama makes a historic visit to Hiroshima. The Taliban choose a new leader after a U.S. drone strike kills Mullah Mansour. And a far right candidate in Austria narrowly loses the presidential election. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, May 27 2016Donald Trump now has enough delegates to clinch the Republican nomination, according to the Associated Press. A State Department review criticizes Hillary Clinton's use of a private email server. And 11 states sue the federal government over a transgender bathroom directive. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top national news stories